Literature DB >> 9226785

Economic evaluation in support of national health policy: the case of The Netherlands.

E Elsinga1, F F Rutten.   

Abstract

This article focuses on economic evaluation as an instrument to support national health policy in the Netherlands. National health policy concerns decision-making on which technologies may enter the health care market, which health care services are included in the package of health care benefits and under what conditions, and what the geographical distribution of medical services and facilities should be. Regarding the latter two issues in particular, the actual and potential role of economic evaluation in health policy is discussed. From the Dutch experience we can learn that a close cooperation between researchers and policy-makers helps to enlarge the impact of economic appraisal on policy-making and that incorporation of the right (financial) incentives is vital to the use of economic appraisal in health care decision-making.

Mesh:

Year:  1997        PMID: 9226785     DOI: 10.1016/s0277-9536(96)00400-5

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  8 in total

1.  Differences in attitudes, knowledge and use of economic evaluations in decision-making in The Netherlands. The Dutch results from the EUROMET Project.

Authors:  J E Zwart-van Rijkom; H G Leufkens; J J Busschbach; A W Broekmans; F F Rutten
Journal:  Pharmacoeconomics       Date:  2000-08       Impact factor: 4.981

2.  Guidelines for appropriate care: the importance of empirical normative analysis.

Authors:  M Berg; R T Meulen; M van den Burg
Journal:  Health Care Anal       Date:  2001

3.  Building better models: if we build them, will policy makers use them? Toward integrating modeling into health care decisions.

Authors:  Jeanne Mandelblatt; Clyde Schechter; David Levy; Ann Zauber; Yaojen Chang; Ruth Etzioni
Journal:  Med Decis Making       Date:  2012 Sep-Oct       Impact factor: 2.583

Review 4.  Abciximab. A pharmacoeconomic review of its use in percutaneous coronary revascularisation.

Authors:  C J Dunn; R H Foster
Journal:  Pharmacoeconomics       Date:  1999-12       Impact factor: 4.981

5.  The role of economic evaluation in the decision-making process of family physicians: design and methods of a qualitative embedded multiple-case study.

Authors:  Chantale Lessard; André-Pierre Contandriopoulos; Marie-Dominique Beaulieu
Journal:  BMC Fam Pract       Date:  2009-02-11       Impact factor: 2.497

Review 6.  Abciximab. An updated review of its use in ischaemic heart disease.

Authors:  R H Foster; L R Wiseman
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

Review 7.  The "health benefit basket" in the Netherlands.

Authors:  Elly A Stolk; Frans F H Rutten
Journal:  Eur J Health Econ       Date:  2005-12

8.  Generalized cost-effectiveness analysis for national-level priority-setting in the health sector.

Authors:  Raymond Hutubessy; Dan Chisholm; Tessa Tan-Torres Edejer
Journal:  Cost Eff Resour Alloc       Date:  2003-12-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.